Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells
- 9 September 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 52 (2) , 311-316
- https://doi.org/10.1002/ijc.2910520226
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of interferons on the expression of the proto‐oncogene her‐2 in human ovarian carcinoma cellsInternational Journal of Cancer, 1992
- Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulationBiochemistry, 1990
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- Prolactin and Glucocorticoid Hormones Control Transcription of the β-Casein Gene by Kinetically Distinct MechanismsMolecular Endocrinology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.Molecular and Cellular Biology, 1989
- Expression of the c‐erbB‐2 protein in normal and transformed cellsInternational Journal of Cancer, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- [89] Radioimmunoassay for detection of changes in cell surface tumor antigen expression induced by interferonPublished by Elsevier ,1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986